The result that homozygosity for JAK2V617F is a risk factor for BT in PMF parallels the finding that accumulation of JAK2 mutated alleles contributes to transformation into myelofibrosis of patients with polycythemia vera [21]. The gene discussed is JAK2; the disease is myelofibrosis.